|
POT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.248590E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.061100E-03 |
| Normal-vs-Stage2 |
1.433630E-01 |
| Normal-vs-Stage3 |
9.671500E-02 |
| Normal-vs-Stage4 |
1.033240E-01 |
| Stage1-vs-Stage2 |
8.695800E-01 |
| Stage1-vs-Stage3 |
8.882800E-01 |
| Stage1-vs-Stage4 |
6.378400E-01 |
| Stage2-vs-Stage3 |
9.720800E-01 |
| Stage2-vs-Stage4 |
7.564400E-01 |
| Stage3-vs-Stage4 |
7.234200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.598100E-04 |
| Normal-vs-AfricanAmerican |
2.618200E-02 |
| Normal-vs-Asian |
5.027200E-01 |
| Caucasian-vs-AfricanAmerican |
8.131400E-01 |
| Caucasian-vs-Asian |
9.046800E-01 |
| AfricanAmerican-vs-Asian |
9.720800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.996800E-04 |
| Normal-vs-Female |
2.283000E-03 |
| Male-vs-Female |
4.947600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.232000E-01 |
| Normal-vs-Extreme_Weight |
3.441500E-02 |
| Normal-vs-Obese |
7.840600E-04 |
| Normal-vs-Extreme_Obese |
8.534800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.587600E-01 |
| Normal_Weight-vs-Obese |
7.283600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.847200E-01 |
| Extreme_Weight-vs-Obese |
2.606000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.098800E-01 |
| Obese-vs-Extreme_Obese |
1.932440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.443000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.204630E-04 |
| Normal-vs-Age(61-80Yrs) |
3.651800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.157200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.795970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.665560E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.811190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.159600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.615800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.238000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.23060000001285E-06 |
| Normal-VS-Type2 PRCC |
7.451600E-01 |
| Normal-VS-KIRP CIMP |
2.943700E-02 |
| Normal-VS-Unclassified PRCC |
4.955600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.971000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.047400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.966600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.398400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.920100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.041400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.848600E-01 |
| Normal-vs-N1 |
2.772400E-02 |
| Normal-vs-N2 |
4.194800E-01 |
| N0-vs-N1 |
6.366300E-02 |
| N0-vs-N2 |
8.510400E-01 |
| N1-vs-N2 |
5.247000E-01 |
|
|
